Vertex Pharmaceuticals (VRTX) Free Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 66.37% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.98% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 137.65% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.37% |
| Dec 31, 2025 | -29.15% |
| Sep 30, 2025 | -12.48% |
| Jun 30, 2025 | 124.26% |
| Mar 31, 2025 | -37.15% |
| Dec 31, 2024 | 178.75% |
| Sep 30, 2024 | 6.05% |
| Jun 30, 2024 | -455.66% |
| Mar 31, 2024 | 44.35% |
| Dec 31, 2023 | -83.11% |
| Sep 30, 2023 | 36.23% |
| Jun 30, 2023 | -1.08% |
| Mar 31, 2023 | -3.90% |
| Dec 31, 2022 | 11.96% |
| Sep 30, 2022 | 3.03% |
| Jun 30, 2022 | 535.30% |
| Mar 31, 2022 | 5.00% |
| Dec 31, 2021 | 110.26% |
| Sep 30, 2021 | 19.35% |
| Jun 30, 2021 | -124.45% |
| Mar 31, 2021 | 6.76% |
| Dec 31, 2020 | 3.39% |
| Sep 30, 2020 | 136.06% |
| Jun 30, 2020 | 128.14% |
| Mar 31, 2020 | 159.58% |
| Dec 31, 2019 | 43.60% |
| Sep 30, 2019 | -13.85% |
| Jun 30, 2019 | 53.17% |
| Mar 31, 2019 | 37.32% |
| Dec 31, 2018 | 62.00% |
| Sep 30, 2018 | 153.60% |
| Jun 30, 2018 | 77.81% |
| Mar 31, 2018 | -12.26% |
| Dec 31, 2017 | 42.01% |
| Sep 30, 2017 | 174.52% |
| Jun 30, 2017 | 558.63% |
| Mar 31, 2017 | 1,039.08% |
| Dec 31, 2016 | 681.99% |
| Sep 30, 2016 | 173.05% |
| Jun 30, 2016 | 120.17% |